The Effect of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Severity and Death Rate of COVID-19 in Iranian Patients

M Samet, M Yazdi, M Tajamolian, M Beygi… - Biochemical …, 2023 - Springer
The study was designed to assess the association of ACE I/D polymorphism with the severity
and prognosis of COVID-19 in the Iranian population. Hence, 186 adult patients were …

Angiotensin-converting enzyme-1 gene insertion/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study

O Gunal, O Sezer, GU Ustun, CE Ozturk… - Annals of Saudi …, 2021 - annsaudimed.net
BACKGROUND: Angiotensin-converting enzyme (ACE) insertion/deletion (I/D)
polymorphism may play a role in the pathogenesis of coronavirus-19 disease (COVID-19) …

The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients

M Rezaei, H Mohammadpour, M Eftekhari… - Frontiers in …, 2022 - frontiersin.org
The pandemic of coronavirus disease in 2019 has led to a global crisis. COVID-19 shows
distinct clinical manifestations of the severity of symptoms. Numerous patients with no …

The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study

A Faridzadeh, M Mahmoudi, S Ghaffarpour… - Frontiers in …, 2022 - frontiersin.org
Background: Since the beginning of the pandemic of coronavirus disease 2019 (COVID-19),
many countries have experienced a considerable number of COVID-19 cases and deaths …

[PDF][PDF] Angiotensin-Converting Enzyme Receptor Genotype and its Activity Level as Potential Predictors of the Severity COVID-19 among Iraqi Patients.

SH Kamel, FJ Al-Tu'ma, RM Al-Saegh - Journal of Contemporary Medical …, 2021 - iasj.net
Objectives: The purpose of this study is to determine whether the angiotensin-converting
enzyme activity and various biomarkers are used to investigate the severity of Covid-19 and …

The association of ACE I/D polymorphism with the severity of COVID-19 in Iranian patients: A case-control study

JS Rezaiezadeh, JS Lord, MS Yekaninejad, P Izadi - Human Gene, 2022 - Elsevier
Background Since the beginning of the COVID-19 pandemic, researchers have tried to find
the reason behind the variety of the symptoms and disease severity among patients. It …

Strong association between angiotensin-converting enzyme gene InDel polymorphism and COVID-19 diseases

H Çobanogullari, EU Evren, H Evren, K Suer… - Medicina Clínica, 2023 - Elsevier
Abstract Background and Objectives The COVID-19 pandemic that emerged in China in late
2019 and spread rapidly around the world. There is evidence that COVID-19 infection can …

The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients

I Fricke-Galindo, I Buendia-Roldan… - International Journal of …, 2023 - mdpi.com
This paper assesses the association of the insertion/deletion ACE (angiotensin-converting
enzyme) variant (rs1799752 I/D) and the serum ACE activity with the severity of COVID-19 …

Angiotensin-converting enzyme 1 and voltage-gated potassium channel-interacting protein 4 gene polymorphisms in COVID-19 patients from east of Iran

H Abbaszadeh, F Mohammadi… - Clinica Chimica …, 2022 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19), the infectious respiratory
disease caused by a newly discovered pathogen (severe acute respiratory syndrome …

Human ace D/I polymorphism could affect the clinicobiological course of COVID-19

E Aladag, Z Tas, BS Ozdemir… - Journal of the Renin …, 2021 - journals.sagepub.com
Introduction. The coronavirus disease 2019 (COVID-19), that is caused by severe acute
respiratory syndrome corona virus 2 (SARS-CoV-2), has spread rapidly worldwide since …